Drug Therapy for Rheumatological Diseases
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 31 January 2026 | Viewed by 473
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue of Pharmaceuticals will explore the multifaceted landscape of drug therapy in rheumatological diseases. We invite submissions that delve into advancements and challenges in managing these complex conditions.
Topics of Interest
We are particularly interested in contributions addressing the following topics:
- Therapeutic drug level monitoring: Optimizing drug efficacy and minimizing toxicity through precise monitoring in various rheumatic diseases.
- New therapies in difficult to treat (refractory) manifestations of rheumatic diseases: Discussing the mechanisms, clinical applications, and outcomes of both groundbreaking new drugs and refined traditional treatments. This includes but is not limited to biologics, small-molecule inhibitors, complement inhibitors, etc., for refractory rheumatoid arthritis, vasculitis, lupus nephritis, discoid lupus, or IgG4 disease.
- Shared decision-making: Examining the crucial role of patient–provider collaboration in selecting and adhering to chronic, life-sustaining medications, empowering patients with rheumatic diseases in their treatment journey.
- Efficacy vs. safety of drug therapy in special conditions like kidney disease, liver disease, gastric bypass, pregnancy, and breastfeeding: Evidence reports and meta-analyses highlighting the safety vs. efficacy of drugs commonly used for rheumatic disease management in special conditions like kidney disease, liver disease, pregnancy, etc.
This issue aims to provide a comprehensive overview of current pharmacological strategies, foster discussions on personalized medicine, and highlight the importance of patient-centered care in rheumatology. We welcome original research, reviews, and commentaries from experts in the field.
Dr. Shivani Garg
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- rheumatology
- drug therapy
- biologics
- DMARDs
- therapeutic drug monitoring
- shared decision-making
- autoimmune diseases
- chronic disease management, safety vs. efficacy of rheumatic disease therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
